Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Novartis Europharm Limited

02 2Novartis Pharma Schweiz Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Capmatinib Dihydrochloride Monohydrate

Brand Name : Tabrecta

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 20/06/2022

Application Number : 20210416000240

Regulatory Info : Approved

Registration Country : Sweden

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Capmatinib Dihydrochloride Monohydrate

Brand Name : Tabrecta

Dosage Form : Film Coated Tablet

Dosage Strength : 200mg

Packaging :

Approval Date : 20/06/2022

Application Number : 20210416000257

Regulatory Info : Approved

Registration Country : Sweden

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Morning Glory

Brand Name : Tabrecta

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 26/04/2021

Application Number : 67648

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Morning Glory

Brand Name : Tabrecta

Dosage Form : Film Coated Tablet

Dosage Strength : 200mg

Packaging :

Approval Date : 26/04/2021

Application Number : 67648

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Capmatinib Dihydrochloride Monohydrate

Brand Name : Table

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date : 2022-07-12

Application Number : 1221650002

Regulatory Info : Authorized

Registration Country : Spain

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Capmatinib Dihydrochloride Monohydrate

Brand Name : Table

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date : 2022-07-12

Application Number : 1221650004

Regulatory Info : Authorized

Registration Country : Spain

blank